Corvus Pharmaceuticals (CRVS) Net Shares Issued and Repurchased (2016)
Corvus Pharmaceuticals' (CRVS) quarterly Net Shares Issued and Repurchased came in at -$1000.0 in Q4 2016, down 100.01% quarter-over-quarter from $7.0 million in Q2 2016.
Corvus Pharmaceuticals (CRVS) Net Shares Issued and Repurchased (2016) Analysis & Trends
Corvus Pharmaceuticals' Net Shares Issued and Repurchased history runs 1 years deep, the most recent figure standing at -$1000.0 for Q4 2016.
- On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to -$1000.0 in Q4 2016; TTM through Dec 2016 was $71.4 million, a N/A change from a year earlier, with the FY2016 full-year figure at $71.4 million, changed N/A from the prior year.
- Net Shares Issued and Repurchased fell to -$1000.0 in Q4 2016 per CRVS's latest filing, from $7.0 million in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $64.3 million in Q1 2016 and bottomed at -$1000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -1,000.00 |
| Dec 31, 2016 | -1,000.00 |
| Jun 30, 2016 | 7.01 Mn |
| Jun 30, 2016 | 7.01 Mn |
| Mar 31, 2016 | 64.34 Mn |
| Mar 31, 2016 | 64.34 Mn |